Finanical Statements
Alexandria Pharmaceuticals (AXPH.CA) Reports 9 Months Results
Published at 18 May 2026 at 15:23Alexandria PharmaceuticalsRelated stock:Alexandria Pharmaceuticals stockAll Alexandria Pharmaceuticals disclosures
Disclosure summary
Company Name : Alexandria Pharmaceuticals
ISIN Code : EGS38341C011
Currency : EGP
F/S Period : From 01/07/2025 To 31/03/2026
Net Profit : 431,240,870
F/S Period: From 01/07/2024 To 31/03/2025
Net Comparative Profit : 323,414,212
Audit Status : Reviewed
Source : Alexandria Pharmaceuticals
The Financial Statements in Arabic & English (6,002 KB)
ISIN Code : EGS38341C011
Currency : EGP
F/S Period : From 01/07/2025 To 31/03/2026
Net Profit : 431,240,870
F/S Period: From 01/07/2024 To 31/03/2025
Net Comparative Profit : 323,414,212
Audit Status : Reviewed
Source : Alexandria Pharmaceuticals
The Financial Statements in Arabic & English (6,002 KB)